SynCardia TAH bridges patient for 119 days to successful heart transplant at UCSF Health

Picard Medical, Inc.

Male patient in his twenties with biventricular heart failure received SynCardia TAH on Nov 15, 2025.
Device provided 119 days of circulatory support; successful heart transplant on March 14, 2026.
Second of five patients at UCSF Health successfully bridged to transplant using SynCardia TAH.
UCSF surgical director Amy Fiedler, MD, noted patient recovering well and praised partnership with SynCardia.
CEO Patrick Schnegelsberg cited growing adoption at leading transplant centers.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.